IRIDEX CORP Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
IRIDEX CORP (IRIX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $3.75 per share for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-18
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-04-04 was $2.89, a 16.71% decline year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-29 was $3.47, a 36.10% decline year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-30 was $5.43, a 33.74% increase year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-04-01 was $4.06, a 56.85% decline year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2026 was $2.99, a 35.84% decline from fiscal 2024.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $4.66, a 7.54% decline from fiscal 2023.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $5.04, a 38.69% decline from fiscal 2022.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $8.22, a 59.92% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-07-04 | $3.75 10-Q · filed 2026-08-18 | |||
| 2026-04-04 | $2.89 10-Q · filed 2026-05-19 | |||
| 2026-01-03 | $2.99 10-K · filed 2026-04-02 | |||
| 2025-09-27 | $3.90 10-Q · filed 2025-11-12 | |||
| 2025-06-28 | $3.53 10-Q · filed 2025-08-12 | |||
| 2025-03-29 | $3.47 10-Q · filed 2025-05-13 | |||
| 2024-12-28 | $4.66 10-K · filed 2026-04-02 | |||
| 2024-09-28 | $4.48 10-Q · filed 2024-11-12 | |||
| 2024-06-29 | $4.68 10-Q · filed 2024-08-08 | |||
| 2024-03-30 | $5.43 10-Q · filed 2024-05-14 | |||
| 2023-12-30 | $5.04 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $5.14 10-Q · filed 2023-11-20 | |||
| 2023-07-01 | $5.55 10-Q · filed 2023-08-10 | |||
| 2023-04-01 | $4.06 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $8.22 10-K · filed 2024-03-29 | |||
| 2022-10-01 | $8.72 10-Q · filed 2022-11-10 | |||
| 2022-07-02 | $8.50 10-Q · filed 2022-08-15 | |||
| 2022-04-02 | $9.41 10-Q · filed 2022-05-12 | |||
| 2022-01-01 | $5.14 10-K · filed 2023-03-09 | |||
| 2021-10-02 | $4.47 10-Q · filed 2021-11-12 | |||
| 2021-07-03 | $4.47 10-Q · filed 2021-08-12 | |||
| 2021-04-03 | $4.54 10-Q · filed 2021-05-12 | |||
| 2021-01-02 | $7.23 10-K · filed 2022-03-15 | |||
| 2020-09-26 | $6.79 10-Q · filed 2020-11-10 | |||
| 2020-06-27 | $6.95 10-Q · filed 2020-08-07 | |||
| 2020-03-28 | $6.76 10-Q · filed 2020-05-12 | |||
| 2019-12-28 | $9.20 10-K · filed 2021-03-23 | |||
| 2019-09-28 | $9.31 10-Q · filed 2019-11-08 | |||
| 2019-06-29 | $9.68 10-Q · filed 2019-08-07 | |||
| 2019-03-30 | $10.16 10-Q · filed 2019-05-07 | |||
| 2018-12-29 | $9.85 10-K · filed 2020-03-13 | |||
| 2018-09-29 | $10.48 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $10.97 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | $11.80 10-Q · filed 2018-05-08 | |||
| 2017-12-30 | $10.47 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $10.50 10-Q · filed 2017-11-07 | |||
| 2017-07-01 | $10.40 10-Q · filed 2017-08-08 | |||
| 2017-04-01 | $11.04 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $7.37 10-K · filed 2018-03-14 | |||
| 2016-10-01 | $8.56 10-Q · filed 2016-11-07 | |||
| 2016-07-02 | $8.58 10-Q · filed 2016-08-08 | |||
| 2016-04-02 | $10.18 10-Q · filed 2016-05-09 | |||
| 2016-01-02 | $4.71 10-K · filed 2018-03-14 | |||
| 2015-10-03 | $4.44 10-Q · filed 2015-11-10 | |||
| 2015-07-04 | $5.98 10-Q · filed 2015-08-10 | |||
| 2015-04-04 | $3.35 10-Q · filed 2015-05-12 | |||
| 2015-01-03 | $6.13 10-K · filed 2017-03-15 | |||
| 2014-09-27 | $6.16 10-Q · filed 2014-11-03 | |||
| 2014-06-28 | $6.28 10-Q · filed 2014-08-04 | |||
| 2014-03-29 | $4.26 10-Q · filed 2014-05-05 | |||
| 2013-12-28 | $5.64 10-K · filed 2016-03-31 | |||
| 2013-09-28 | $5.54 10-Q · filed 2013-11-04 | |||
| 2013-06-29 | $4.41 10-Q · filed 2013-08-05 | |||
| 2013-03-30 | $4.06 10-Q · filed 2013-05-06 | |||
| 2012-12-29 | $4.35 10-K · filed 2015-04-02 | |||
| 2012-09-29 | $4.32 10-Q · filed 2012-11-05 | |||
| 2012-06-30 | $4.62 10-Q · filed 2012-08-07 | |||
| 2011-12-31 | $4.88 10-K · filed 2014-03-27 | |||
| 2011-01-01 | $7.54 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |